Cargando…

Efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke

The purpose of the study was to investigate the efficacy and safety of Cerebrolysin in patients with hemorrhagic stroke. The primary objective of this trial was to assess the clinical efficacy and safety of a 10–days course of therapy with a daily administration of Cerebrolysin (50 mL Ⅳ per day). Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajenaru, O, Tiu, C, Moessler, H, Antochi, F, Muresanu, D, Popescu, BO, Novak, P
Formato:	Texto
Lenguaje:	English
Publicado:	Carol Davila University Press 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019043/ https://www.ncbi.nlm.nih.gov/pubmed/20968198

Ejemplares similares

Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials
por: Guekht, Alla, et al.
Publicado: (2017)

Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery
por: Jianu, DC, et al.
Publicado: (2010)

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
por: Muresanu, Dafin F., et al.
Publicado: (2016)

Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials
por: Bornstein, Natan M., et al.
Publicado: (2017)

Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial
por: Gharagozli, K, et al.
Publicado: (2017)

Role and Impact of Cerebrolysin for Ischemic Stroke Care
por: Mureșanu, Dafin F., et al.
Publicado: (2022)

Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure
por: Rockenstein, Edward, et al.
Publicado: (2014)

Efficacy of Cerebrolysin in the reduction of spasticity during stroke rehabilitation
por: Martinez, RM
Publicado: (2017)

Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
por: Strilciuc, Stefan, et al.
Publicado: (2023)

Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin Plus Donepezil in Patients With Advanced Alzheimer’s Disease
por: Alvarez, X Anton, et al.
Publicado: (2020)

Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Danfeng, et al.
Publicado: (2017)

Randomized, placebo-controlled, double-blind, pilot trial to investigate safety and efficacy of Cerebrolysin in patients with aneurysmal subarachnoid hemorrhage
por: Woo, Peter Y. M., et al.
Publicado: (2020)

Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin
por: Onose, G, et al.
Publicado: (2009)

Synergistic Increase of Serum BDNF in Alzheimer Patients Treated with Cerebrolysin and Donepezil: Association with Cognitive Improvement in ApoE4 Cases
por: Alvarez, X. Anton, et al.
Publicado: (2016)

The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury Patients: A CAPTAIN II Retrospective Trial Analysis
por: Mureșanu, Ioana Anamaria, et al.
Publicado: (2022)

Cerebrolysin administration reduces oxidative stress-induced apoptosis in limphocytes from healthy individuals
por: Formichi, Patrizia, et al.
Publicado: (2012)

Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
por: Kojder, Klaudyna, et al.
Publicado: (2023)

Role of Cerebrolysin(®) in Rehabilitation in Ischemic Stroke: A Case Report
por: Chanubol, Ratanapat, et al.
Publicado: (2021)

Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson’s Disease
por: Rockenstein, Edward, et al.
Publicado: (2016)

Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review
por: Park, Yung Ki, et al.
Publicado: (2018)

Cerebrolysin and repetitive transcranial magnetic stimulation (rTMS) in patients with traumatic brain injury: a three-arm randomized trial
por: Verisezan Rosu, Olivia, et al.
Publicado: (2023)

Correction to: Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review
por: Park, Yung Ki, et al.
Publicado: (2019)

The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score in Moderate and Severe Traumatic Brain Injury
por: Birle, Codruta, et al.
Publicado: (2020)

Celebrating the legacy of Prof. Ovidiu Alexandru Bajenaru
por: Muresanu, Dafin, et al.
Publicado: (2022)

Nociceptive pain unmasking a serious pathology – paraneoplastic hypertrophic osteoarthropathy: A case report
por: Ribigan, Athena Cristina, et al.
Publicado: (2019)

Cerebrolysin effects on neurological outcomes and cerebral blood flow in acute ischemic stroke
por: Amiri-Nikpour, Mohammad Reza, et al.
Publicado: (2014)

Shared Decision-Making to Improve Health-Related Outcomes for Adults with Stroke Disease
por: Bajenaru, Lidia, et al.
Publicado: (2023)

Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
por: Chemer, Nataliia, et al.
Publicado: (2019)

The Avant Rehabilitation Program and Cerebrolysin for Treatment of Post-Stroke Dysphagia: A Case Report
por: Hien, Nguyen Minh, et al.
Publicado: (2019)

Differences in clinical and biological factors between patients with PFO-related stroke and patients with PFO and no cerebral vascular events
por: Badea, Raluca Ştefania, et al.
Publicado: (2023)

Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study
por: Khasanova, Dina R., et al.
Publicado: (2023)

Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials
por: Strilciuc, Stefan, et al.
Publicado: (2021)

Plasmatic markers in hemorrhagic stroke
por: Marginean, IC, et al.
Publicado: (2011)

Cerebrolysin combined with rehabilitation promotes motor recovery in patients with severe motor impairment after stroke
por: Chang, Won Hyuk, et al.
Publicado: (2016)

Effects of Cerebrolysin® in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study
por: Kim, Jun Yup, et al.
Publicado: (2019)

Romanian registry for interventional treatment in acute stroke: a hope for secondary prevention through medication adherence improvement
por: Tiu, Cristina, et al.
Publicado: (2023)

Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal: Possible New Therapy for Pain Management
por: Sharma, Hari S, et al.
Publicado: (2011)

Safety and Efficacy of Cerebrolysin in Infants with Communication Defects due to Severe Perinatal Brain Insult: A Randomized Controlled Clinical Trial
por: Hassanein, Sahar M.A., et al.
Publicado: (2016)

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
por: Jarosz, Konrad, et al.
Publicado: (2023)

Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials
por: Wang, Zefeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bcq7ruqkb0kktb53pisj4af6nf